HHS Secretary Statement on FDA Reauthorization Act of 2017

HHS News

Government / HHS News 8 Views

Health and Human Services Secretary Tom Price, M.D. issued the following statement on the FDA Reauthorization Act of 2017:

“Congress is to be commended for passing the FDA Reauthorization Act of 2017. This bill is a vital first step to accomplishing our goal of expanding access to affordable, life-saving drugs and medical devices in a thoughtful manner that protects taxpayer resources, promotes competition, improves healthcare outcomes, and stimulates scientific innovation and medical advances. We welcome this progress.  To accomplish this goal more fully for the American people, more work remains to be done. Together with FDA Commissioner, Dr. Scott Gottlieb, we will continue to work with Congress to ensure that FDA remains the gold standard in advancing medical breakthroughs that will improve the health and well-being of the American people.”